About Us
Our Technology
Alzheimer's
Pipeline
More
August 9, 2023
Sunbird Bio Merges with Glympse Bio to Accelerate Development of Proprietary Protein-Based Diagnostic Technologies
June 8, 2022
Glympse to Present Two Posters Demonstrating Novel Protease Biosensor Diagnostic Platform Detection of Hepatocellular Carcinoma at EASL ILC 2022
October 24, 2022
Sunbird Bio Appoints Peter Maimonis, Ph.D., as Chief Technology Officer